vs
Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and BWX Technologies, Inc. (BWXT). Click either name above to swap in a different company.
BWX Technologies, Inc. is the larger business by last-quarter revenue ($885.8M vs $564.0M, roughly 1.6× American Healthcare REIT, Inc.). BWX Technologies, Inc. runs the higher net margin — 10.5% vs 1.9%, a 8.6% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (18.7% vs 13.5%). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (21.1% CAGR vs 11.7%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.
AHR vs BWXT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $564.0M | $885.8M |
| Net Profit | $10.8M | $93.0M |
| Gross Margin | 14.8% | — |
| Operating Margin | 19.8% | 10.4% |
| Net Margin | 1.9% | 10.5% |
| Revenue YoY | 13.5% | 18.7% |
| Net Profit YoY | 133.9% | 30.9% |
| EPS (diluted) | $0.07 | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $564.0M | $885.8M | ||
| Q3 25 | $532.1M | $866.3M | ||
| Q2 25 | $501.3M | $764.0M | ||
| Q1 25 | $497.2M | $682.3M | ||
| Q4 24 | $496.8M | $746.3M | ||
| Q3 24 | $476.8M | $672.0M | ||
| Q2 24 | $458.0M | $681.5M | ||
| Q1 24 | $452.1M | $604.0M |
| Q4 25 | $10.8M | $93.0M | ||
| Q3 25 | $55.9M | $82.1M | ||
| Q2 25 | $9.9M | $78.4M | ||
| Q1 25 | $-6.8M | $75.5M | ||
| Q4 24 | $-31.8M | $71.0M | ||
| Q3 24 | $-4.1M | $69.5M | ||
| Q2 24 | $2.0M | $73.0M | ||
| Q1 24 | $-3.9M | $68.5M |
| Q4 25 | 14.8% | — | ||
| Q3 25 | 14.6% | 21.8% | ||
| Q2 25 | 15.0% | 25.1% | ||
| Q1 25 | 13.0% | 24.2% | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 12.5% | 24.4% | ||
| Q2 24 | 12.1% | 24.7% | ||
| Q1 24 | 10.7% | 24.6% |
| Q4 25 | 19.8% | 10.4% | ||
| Q3 25 | 19.9% | 13.1% | ||
| Q2 25 | 20.6% | 13.4% | ||
| Q1 25 | 19.0% | 14.2% | ||
| Q4 24 | 20.0% | 12.4% | ||
| Q3 24 | 19.6% | 14.4% | ||
| Q2 24 | 19.4% | 14.5% | ||
| Q1 24 | 18.2% | 15.4% |
| Q4 25 | 1.9% | 10.5% | ||
| Q3 25 | 10.5% | 9.5% | ||
| Q2 25 | 2.0% | 10.3% | ||
| Q1 25 | -1.4% | 11.1% | ||
| Q4 24 | -6.4% | 9.5% | ||
| Q3 24 | -0.9% | 10.3% | ||
| Q2 24 | 0.4% | 10.7% | ||
| Q1 24 | -0.9% | 11.3% |
| Q4 25 | $0.07 | $1.02 | ||
| Q3 25 | $0.33 | $0.89 | ||
| Q2 25 | $0.06 | $0.85 | ||
| Q1 25 | $-0.04 | $0.82 | ||
| Q4 24 | $-0.23 | $0.77 | ||
| Q3 24 | $-0.03 | $0.76 | ||
| Q2 24 | $0.01 | $0.79 | ||
| Q1 24 | $-0.04 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.8M | $499.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.3B | $1.2B |
| Total Assets | $5.4B | $4.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.8M | $499.8M | ||
| Q3 25 | $147.4M | $79.6M | ||
| Q2 25 | $133.5M | $37.0M | ||
| Q1 25 | $86.1M | $55.4M | ||
| Q4 24 | $76.7M | $74.1M | ||
| Q3 24 | $67.8M | $35.5M | ||
| Q2 24 | $52.1M | $48.3M | ||
| Q1 24 | $77.0M | $45.9M |
| Q4 25 | $3.3B | $1.2B | ||
| Q3 25 | $2.7B | $1.2B | ||
| Q2 25 | $2.4B | $1.2B | ||
| Q1 25 | $2.3B | $1.1B | ||
| Q4 24 | $2.3B | $1.1B | ||
| Q3 24 | $2.2B | $1.1B | ||
| Q2 24 | $1.9B | $998.5M | ||
| Q1 24 | $2.0B | $946.2M |
| Q4 25 | $5.4B | $4.3B | ||
| Q3 25 | $4.8B | $3.8B | ||
| Q2 25 | $4.5B | $3.7B | ||
| Q1 25 | $4.5B | $3.1B | ||
| Q4 24 | $4.5B | $2.9B | ||
| Q3 24 | $4.7B | $2.9B | ||
| Q2 24 | $4.6B | $2.8B | ||
| Q1 24 | $4.7B | $2.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.2M | $127.0M |
| Free Cash FlowOCF − Capex | — | $56.8M |
| FCF MarginFCF / Revenue | — | 6.4% |
| Capex IntensityCapex / Revenue | — | 7.9% |
| Cash ConversionOCF / Net Profit | 5.12× | 1.37× |
| TTM Free Cash FlowTrailing 4 quarters | — | $295.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.2M | $127.0M | ||
| Q3 25 | $107.2M | $143.2M | ||
| Q2 25 | $71.5M | $159.0M | ||
| Q1 25 | $60.6M | $50.6M | ||
| Q4 24 | $59.5M | $276.9M | ||
| Q3 24 | $63.1M | $32.6M | ||
| Q2 24 | $59.4M | $65.9M | ||
| Q1 24 | $-6.0M | $33.0M |
| Q4 25 | — | $56.8M | ||
| Q3 25 | — | $94.9M | ||
| Q2 25 | — | $126.3M | ||
| Q1 25 | — | $17.3M | ||
| Q4 24 | — | $224.4M | ||
| Q3 24 | — | $-7.7M | ||
| Q2 24 | — | $35.5M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | — | 6.4% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 30.1% | ||
| Q3 24 | — | -1.1% | ||
| Q2 24 | — | 5.2% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | — | 7.9% | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | 5.12× | 1.37× | ||
| Q3 25 | 1.92× | 1.74× | ||
| Q2 25 | 7.21× | 2.03× | ||
| Q1 25 | — | 0.67× | ||
| Q4 24 | — | 3.90× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | 30.02× | 0.90× | ||
| Q1 24 | — | 0.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
BWXT
| Nuclear Component Program | $436.4M | 49% |
| Nuclear Manufacturing | $134.8M | 15% |
| Cost Plus Fee | $116.1M | 13% |
| Uranium And Nuclear Services | $103.8M | 12% |
| Commercial Operations | $49.0M | 6% |
| Commercial Operations Segment | $33.7M | 4% |
| Transferred At Point In Time | $1.3M | 0% |
